The Induced Pluripotent Stem Cell (iPSC) Core at Cedars-Sinai in the Biomanufacturing Center at Cedars-Sinai uses the latest techniques to reprogram, expand, and characterize human iPSCs from human skin or blood tissues of healthy subjects and diseased patients. iPSCs are then turned into specific cells of the human body including components of the nervous system, eyes, blood, bones, heart, gut, liver, and pancreas, for use by researchers. Applications of this technology include human disease modeling-in-a-dish, developing human reporter cell lines via genetic modification, drug screening on pathological human cell types, and potentially developing cell replacement or regenerative therapies. The iPSC Core offers: (1) iPSC generation and characterization (QC) services, (2) SNP array to asses cytogenetic abnormalities, (3) bio-banking and iPSC thawing, (4) imaging services, (5) extensive iPSC line catalog, (6) cell differentiation services, (7) gene editing, and (8) iPSC culture training.

For more information, please visit the Biomanufacturing Center site.

Last updated
September 01, 2022